Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: combined analysis of two cohorts P Sharma, S López-Tarruella, JA García-Saenz, C Ward, CS Connor, ... Clinical cancer research 23 (3), 649-657, 2017 | 139 | 2017 |
Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel P Sharma, S López-Tarruella, JA García-Saenz, QJ Khan, HL Gómez, ... Clinical Cancer Research 24 (23), 5820-5829, 2018 | 109 | 2018 |
Predictors for survival with cabazitaxel (CBZ) in metastatic, castration-resistant prostate cancer (mCRPC): Long term follow-up of the Spanish registry. I González-Maeso, N Lainez, D Castellano, I Garcia Carbonero, ... Journal of Clinical Oncology 35 (6_suppl), e602-e602, 2017 | | 2017 |
Mesenteric extragastrointestinal stromal tumor (EGIST): a rare variant with unusual behaviour B Peláez-Lorenzo, CA Rodríguez Arias, LA Mata Juberías Revista Colombiana de Cancerología 20 (2), 87-91, 2016 | | 2016 |
Tumor del estroma extragastrointestinal (EGIST) mesentérico: entidad rara con evolución atípica B Peláez-Lorenzo, CAR Arias, LAM Juberías Revista Colombiana de Cancerología 20 (2), 87-91, 2016 | | 2016 |
Consistent benefit survival with cabazitaxel (CBZ) in metastatic castration resistant prostate cancer (mCRPC) in Spain: Updated results. I Gonzalez, DE Castellano, E Esteban, Q Perez Arnillas, J Munarriz, ... Journal of Clinical Oncology 32 (15_suppl), e16088-e16088, 2014 | | 2014 |
Control evolutivo del paciente infectado por el VIH. Cofactores de progresión XCO de Barrón, DA Legarda, BP Lorenzo | | |